Brief: Biorestorative Therapies Reports Positive Phase 2 Blinded Data For Brtx-100
30/03/2026 14:49
March 30 (Reuters) - BioRestorative Therapies Inc BRTX.O: BIORESTORATIVE THERAPIES REPORTS POSITIVE PHASE 2 BLINDED DATA FOR BRTX-100 DEMONSTRATING MEANINGFUL IMPROVEMENTS IN PAIN AND FUNCTION IN CHRONIC LUMBAR DISC DISEASE BIORESTORATIVE THERAPIES INC - REPORTS PHASE 2 DATA FOR BRTX-100 WITH 50%+ PATIENTS SHOWING >50% IMPROVEMENT BIORESTORATIVE THERAPIES INC - NO ADVERSE EVENTS RELATED TO DOSE-LIMITING TOXICITIES ASSOCIATED WITH HYPOXIC-CULTURED MESENCHYMAL STEM CELLS Source text: ID:nGNX3K33mT Further company coverage: BRTX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biorestorative Therapies
See all newsBioRestorative Therapies Inc expected to post a loss of $2.50 a share - Earnings Preview
BioRestorative Therapies Inc expected to post a loss of $2.50 a share - Earnings Preview
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM